Fluoxetine
medicationSSRI antidepressant (brand name: Prozac). One of the most widely prescribed antidepressants worldwide.
Reported Benefits
The multifaceted effects of fluoxetine treatment on cognitive functions.
Not specified in available data
Sustained attention and vigilance were negatively affected in healthy adults treated with fluoxetine.
The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor symptoms of Parkinson's disease.
Not specified in source
A comprehensive meta-analysis of 87 randomized clinical trials involving 9,087 patients demonstrated that fluoxetine is safe and effective for treating depression from the first week of therapy, with significantly greater remission and response rates compared to placebo and a favorable safety profile relative to tricyclic antidepressants.
The multifaceted effects of fluoxetine treatment on cognitive functions.
Not specified in available data
Sustained attention and vigilance were negatively affected in healthy adults treated with fluoxetine.
The multifaceted effects of fluoxetine treatment on cognitive functions.
Not specified in available data
Sustained attention and vigilance were negatively affected in healthy adults treated with fluoxetine.
The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor symptoms of Parkinson's disease.
Not specified in source
A comprehensive meta-analysis of 87 randomized clinical trials involving 9,087 patients demonstrated that fluoxetine is safe and effective for treating depression from the first week of therapy, with significantly greater remission and response rates compared to placebo and a favorable safety profile relative to tricyclic antidepressants.
Reported Side Effects
The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor symptoms of Parkinson's disease.
Not specified in source
A comprehensive meta-analysis of 87 randomized clinical trials involving 9,087 patients demonstrated that fluoxetine is safe and effective for treating depression from the first week of therapy, with significantly greater remission and response rates compared to placebo and a favorable safety profile relative to tricyclic antidepressants.
Related health conditions
Research showing how this habit affects specific health conditions. Always consult healthcare professionals.
May Help With
Major depressive disorder or persistent depressive symptoms
The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor symptoms of Parkinson's disease.
Not specified in source
A comprehensive meta-analysis of 87 randomized clinical trials involving 9,087 patients demonstrated that fluoxetine is safe and effective for treating depression from the first week of therapy, with significantly greater remission and response rates compared to placebo and a favorable safety profile relative to tricyclic antidepressants.
The multifaceted effects of fluoxetine treatment on cognitive functions.
Not specified in available data
Sustained attention and vigilance were negatively affected in healthy adults treated with fluoxetine.
May Worsen
A chronic inflammatory bowel disease that affects the lining of the digestive tract, causing abdominal pain, severe diarrhea, fatigue, weight loss, and malnutrition.
Fluoxetine for Maintenance of Remission and to Improve Quality of Life in Crohn's Disease
Not specified in source
A 12-month randomized double-blind placebo-controlled trial of 26 participants with Crohn's disease found that fluoxetine 20 mg daily was not superior to placebo in maintaining remission or improving quality of life, though the study was small and underpowered.
Research (3 studies)
Community updates
No updates yet for this supplement.
Be the first to share your experience!